Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tonghua Fangda Pharmaceutical is a comprehensive pharmaceutical enterprise based in Tonghua, Jilin Province, China. Founded in 1995, the company focuses on the integration of research, development, manufacturing, and marketing of pharmaceutical products. Its portfolio includes a wide range of Traditional Chinese Medicines (TCM) and chemical drugs, with a particular emphasis on cardiovascular, cerebrovascular, and respiratory therapeutic areas. The company's manufacturing facilities are GMP-certified, supporting the production of various dosage forms such as tablets, capsules, and granules. Tonghua Fangda is recognized as a key high-tech enterprise in its region and has been listed on China's National Equities Exchange and Quotations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tonghua Fangda Pharmaceutical.